Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

LeenLife Pharma International Granting of Stock Options

LNLHF

(TheNewswire)

Vancouver, BC / TheNewswire / December 27, 2017 - LeenLife Pharma International - The Company has gran ted stock options to directors, officers and consultants to purchase up to a total 2,000,000 common shares, exercisable at a price of $0.25 per share. The stock options are exercisable for three years until December 26, 2020. All of the above-mentioned options have been granted pursuant to the Company's Stock Option Plan which was approved by the Company's shareholders on June 8, 2017 at its Annual General Meeting.

About the Company and the Market:

LeenLife products are extracted from flax seeds, a plentiful grain, an organic and a non-animal source. The products can be used as a food additive or as a nutraceutical and have been used in making bread, noodles, cheese, yogurt, juice and milk products for the European market. Their industry leading Omega 3 product formulations are of the highest quality with no cholesterol and toxic substances and are offered as an oil, emulsion and powder.

The global Omega 3 market was valued at 10 billion USD in 2016 and is expected to reach 16 billion USD by the end of 2023, growing at a CAGR of 7.57% between 2016 and 2023.

For more information, please contact:

Stan Lis, CEO

Tel:  604 764-0518

E-mail: slis@leenlifepharma.com

Forward-looking Information

Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including statements that address the Transaction and the meeting of shareholders and those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs and the ability to achieve goals.

 

Copyright (c) 2017 TheNewswire - All rights reserved.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today